Blood Substitutes and Oxygen Therapeutics: An Overview and Current Status
Authors:
- Jonathan S. JahrJJJonathan S. Jahr
- Susmita B. NesargiSNSusmita B. Nesargi
- Kenneth LewisKLKenneth Lewis
- Calvin JohnsonCJCalvin Johnson
- 1 September 2002
- journal article
- review article
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 9 (5) , 437-443
Abstract
This review article discusses the development and implementation of a number of blood substitutes, including hemoglobin-based oxygen carriers (HBOCs) and perfluorocarbons. This review article will introduce the reader to blood substitutes by discussing an overview of an ideal blood substitute, the history of HBOCs and perfluorocarbons, strategies of oxygen carrying, side effects of HBOCs and perfluorocarbons, current clinical trials, and the future of blood substitutes.Keywords
This publication has 27 references indexed in Scilit:
- Eliminating Blood TransfusionsAnesthesiology, 2000
- Blood substitutesCritical Care Medicine, 2000
- Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutionsBritish Medical Bulletin, 1999
- Benefits of leukocyte-reduced blood transfusions in surgical patientsCurrent Opinion in Hematology, 1998
- Aprotinin and antifibrinolytics in cardiopulmonary bypass bleedingSeminars in Anesthesia, Perioperative Medicine and Pain, 1998
- Modified hemoglobin blood substitutes: present status and future perspectives1998
- Association of mortality with age of blood transfused in septic ICU patientsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1997
- Practice Guidelines for Blood Component TherapyAnesthesiology, 1996
- Clinical Experience with Hemoglobin-Saline SolutionsJournal of Applied Physiology, 1949
- On the use of ringer‐locke solutions containing hemoglobin as a substitute for normal blood in mammalsJournal of Cellular and Comparative Physiology, 1934